Surface Transportation Board Resumes Review of Union Pacific–Norfolk Southern Merger, Boosting UNP Stock

Union Pacific (NYSE: UNP) saw renewed investor attention this week following a key update in its proposed merger with Norfolk Southern. On August 18, the U.S. Surface Transportation Board (STB) announced it has resumed consideration of the merger application, marking a fresh material development in the regulatory process.

The STB’s move to restart its evaluation of the proposed merger, which would create America’s first true transcontinental railroad, comes after several months of paused review. This development was reported by Reuters on August 18 and cited by Investing.com the same day.

The proposed merger—valued at roughly $85 billion—has already drawn scrutiny for the market share concentration it would create. Union Pacific and Norfolk Southern have pledged to submit additional information and customer protections, including a binding Memorandum of Understanding with Canadian National (CN) to secure competitive access as part of the deal. Yet until this week, the STB review had been effectively on hold.

Why This Matters for Union Pacific

Resumption of STB review is a critical regulatory hurdle being cleared and may reduce uncertainty around the timeline of this landmark merger. The deal has significant implications for Union Pacific’s network integration, competitive positioning, and long-term growth strategy.

Stock Market Reaction

As of August 21, Union Pacific’s stock traded at $308.05, reflecting a 0.58% increase—though the precise linkage between this rise and the merger resumption has not been explicitly confirmed by reporting. Additional intraday or movement data beyond this closing price was not made available.

Context and Background

Union Pacific’s attempt to merge with Norfolk Southern has been under regulatory review since early 2026. In June, Ups and CN signed a binding MOU to support competitive access tied to the merger under the STB’s oversight. Union Pacific also reported record second-quarter 2026 financial results in July, highlighting strong earnings performance and operational metrics.

Still, the merger’s final approval remains uncertain. The STB’s resumed review is a necessary step, but there is no guarantee of approval, especially amid broader regulatory and antitrust scrutiny.

Investors should watch the STB’s timeline closely, including any further data submissions, hearings, or rulings that may occur as the agency reassesses the application.

Note: Stock price and change reflect closing price as of August 21. Any attribution of causation between regulatory developments and price movement should be treated with caution unless explicitly supported by reporting.